[HTML][HTML] Phase III randomized trial of weekly cisplatin and irradiation versus cisplatin and tirapazamine and irradiation in stages IB2, IIA, IIB, IIIB, and IVA cervical …

PA DiSilvestro, S Ali, PS Craighead… - Journal of clinical …, 2014 - ncbi.nlm.nih.gov
Purpose This prospective, randomized phase III intergroup trial of the Gynecologic Oncology
Group and National Cancer Institute of Canada Clinical Trials Group was designed to test …

PIK3CA mutational status and overall survival in patients with cervical cancer treated with radical chemoradiotherapy

JB McIntyre, JS Wu, PS Craighead, T Phan… - Gynecologic …, 2013 - Elsevier
OBJECTIVE: Mutational activation of PIK3CA is associated with poor prognosis in patients
with solid tumors, and may predict favorable response to PI3K/AKT/mTOR pathway inhibitors. …

An effective group psychoeducational intervention for improving compliance with vaginal dilation: a randomized controlled trial

SA Jeffries, JW Robinson, PS Craighead… - International Journal of …, 2006 - Elsevier
Purpose: Although vaginal dilation is often recommended to minimize or prevent vaginal
scarring after pelvic radiotherapy, compliance with this recommendation has historically been …

A phase I/II evaluation of tirapazamine administered intravenously concurrent with cisplatin and radiotherapy in women with locally advanced cervical cancer

PS Craighead, R Pearcey, G Stuart - International Journal of Radiation …, 2000 - Elsevier
Purpose: This is a Phase I/II dose escalation study to determine the tolerable dose of
tirapazamine (TPZ), and the toxicity of a regimen using TPZ with cisplatin, and radiotherapy in …

Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994

PS Craighead, K Sait, GC Stuart, K Arthur, J Nation… - Gynecologic …, 2000 - Elsevier
Objective. The aim of this study was to determine the patient characteristics and outcome of
patients with aggressive histologic variants (AV) of endometrial carcinoma, including uterine …

Image-guided brachytherapy for cervical cancer: a Canadian Brachytherapy Group survey

S Pavamani, DP D'Souza, L Portelance, PS Craighead… - Brachytherapy, 2011 - Elsevier
PURPOSE: To survey the current use and future plans for image-guided brachytherapy (BT)
for cervical cancer by radiation oncologists in Canada. METHODS AND MATERIALS: …

Low ERCC1 mRNA and protein expression are associated with worse survival in cervical cancer patients treated with radiation alone

…, AC Klimowicz, SK Petrillo, PS Craighead… - Radiotherapy and …, 2010 - Elsevier
PURPOSE: To evaluate the association of excision repair cross-complementation group 1 (ERCC1)
expression, using both mRNA and protein expression analysis, with clinical …

The significance of tumoral ERCC1 status in patients with locally advanced cervical cancer treated with chemoradiation therapy: a multicenter clinicopathologic …

…, SK Petrillo, M Milosevic, PS Craighead… - International Journal of …, 2013 - Elsevier
PURPOSE: ERCC1 (excision repair cross-complementation group 1) expression has been
shown to be a molecular marker of cisplatin resistance in many tumor sites, but has not been …

Phase II study assessing the feasibility of using elemental supplements to reduce acute enteritis in patients receiving radical pelvic radiotherapy

PS Craighead, S Young - American journal of clinical oncology, 1998 - journals.lww.com
From June 1994 through September 1995, 17 patients with gynecologic cancer were
entered into a feasibility study using elemental supplements (ES) during the course of pelvic …

Defining treatment for brain metastases patients: nihilism versus optimism

PS Craighead, A Chan - Supportive Care in Cancer, 2012 - Springer
Aims Treatment of brain metastases patients has included whole brain radiotherapy (WBRT)
for over 50 years, and there is much data showing this to be associated with short-term …